Abstract:Poly(lactic-co-glycolic acid) (PLGA) has garnered increasing attention as a candidate drug delivery polymer owing to its favorable properties, including its excellent biocompatibility, biodegradability, non-toxicity, non-immunogenicity, and mechanical strength. PLAG are specifically used as microspheres for the sustained/controlled and targeted delivery of hydrophilic or hydrophobic drugs, as well as biological therapeutic macromolecules, including peptide and protein drugs. PLGAs with different molecular weights, lactic acid (LA)/glycolic acid (GA) ratios, and end groups exhibit unique release characteristics, which is beneficial for obtaining diverse therapeutic effects. This review aims to analyze the composition of PLGA microspheres, and understand the manufacturing process involved in their production, from a quality by design perspective. Additionally, the key factors affecting PLGA microsphere development are explored as well as the principles involved in the synthesis and degradation of PLGA and its interaction with active drugs. Further, the effects elicited by microcosmic conditions on PLGA macroscopic properties, are analyzed. These conditions include variations in the organic phase (organic solvent, PLGA, and drug concentration), continuous phase (emulsifying ability), emulsifying stage (organic phase and continuous phase interaction, homogenization parameters), and solidification process (relationship between solvent volatilization rate and curing conditions). The challenges in achieving consistency between batches during manufacturing are addressed, and continuous production is discussed as a potential solution. Finally, potential critical quality attributes are introduced, which may facilitate the optimization of process parameters.

Decoration and Application of PLGA Microspheres

PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application

Hollow Polyelectrolyte Microcapsules As Advanced Drug Delivery Carriers

Research Progress on the Application of Porous PLGA Microspheres

Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review

Latest Research Progress of Drug Stability and Release of PLGA Microspheres

PLGA-based drug delivery system for combined therapy of cancer: research progress

Bridging the gap between fundamental research and product development of long acting injectable PLGA microspheres

Recent Applications of PLGA in Drug Delivery Systems

Poly(lactide-co-glycolide) microspheres with good biocompatibility

Microfluidic preparation of monodisperse PLGA-PEG/PLGA microspheres with controllable morphology for drug release.

Preparation Of Monodisperse Biodegradable Polylactic Acid Microspheres Using A Simple Microfluidic Approach

Recent Advances in the Preparation Progress of Protein/peptide Drug Loaded PLA/PLGA Microspheres.

Optimization and characterization of chemically modified polymer microspheres and their effect on cell behavior

PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo

Drug-nanoencapsulated PLGA Microspheres Prepared by Emulsion Electrospray with Controlled Release Behavior

[Preparation, Characterization and Drug Release Characteristics of Poly(lactide)(pl)/poly(lactide-Co-polyethylene Glycol)(pleg) Blend Microspheres].

Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-α,β-[N-(2-hydroxyethyl)-l-aspartamide]-g-poly(l-lactide) graft copolymers

Fabrication of Nonporous and Porous Cationic Plga Microspheres

Composite Core-Shell Microparticles from Microfluidics for Synergistic Drug Delivery

Current Status and Future Developments of Biopolymer Microspheres in the Field of Pharmaceutical Preparation